Maybe there was a mole at the East Area POA and they caught a glimpse of how little 90% of attendees could not give a rip any more. Or the incessant bitching and crying. Could be either.
yhe stock change last week might, maybe, possibly have had something to do with Trumps executive order killing Obamacare, and killing insurance subsidies, and hurting a poor persons chance at getting decent coverage, including coverage for drugs, like diabetes drugs, basically affecting our business. Have u seen the insurance companies performance or trumps tweets about insurance companies windfall being over? Do you read anything else besides Cafepharma?
Actually, I do read. Your argument doesn't hold water because other pharma stocks were up. The insurers were down. LLY and SNY were not. If it was a macro issue like that, you'd expect the entire sector to be affected. NVO was down 3% in a vacuum. I suspect there were people who got the FDA docs early and saw the retinopathy data on sema and we're spooked. That's just a theory tho.
NVO is up $1.03 to $50.43 during pre-market activity. (overseas trading) FDA Advisory Committee meeting for semaglutide approval recommendation is today. NVO shares are up over 40% since January 2017.
If I was you I’d probably not make any bets on anything anytime soon! 17-0 with 1 abstention. Great guess though!
This company and its stock are so overinflated. Wait until we're delayed with sema and will fall through the floor.
